Dr. Chapman From Memorial Sloan-Kettering Cancer Center Describes Recent Melanoma Advances
Paul Chapman, MD, From Memorial Sloan-Kettering Cancer Center describes recent melanoma advances.
Dr. Chapman says there are now two drugs that improve survival in patients with metastatic melanoma. He adds that this has never happened before in melanoma because only two years ago there was no drug that was shown to improve survival in patients. He says physicians now have choices. While the drugs still need to be improved, they are a start and something that can be built upon in terms of combination therapies.